HSP90AA1 and prostate carcinoma: The results of many studies suggest that there are a number of dynamic interactions between client proteins and the HSP40/HSP70/HSP90 chaperone machinery in prostate cancer cells, including CRPC, which is consistent with the pleiotropic nature of molecular chaperones.